Viia Valge-Archer

5.3k total citations
27 papers, 2.4k citations indexed

About

Viia Valge-Archer is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Viia Valge-Archer has authored 27 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 15 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in Viia Valge-Archer's work include Immune Cell Function and Interaction (11 papers), Cancer Immunotherapy and Biomarkers (8 papers) and T-cell and B-cell Immunology (6 papers). Viia Valge-Archer is often cited by papers focused on Immune Cell Function and Interaction (11 papers), Cancer Immunotherapy and Biomarkers (8 papers) and T-cell and B-cell Immunology (6 papers). Viia Valge-Archer collaborates with scholars based in United Kingdom, United States and France. Viia Valge-Archer's co-authors include Anjana Rao, Jugnu Jain, Janice M. Reichert, Patricia G. McCaffrey, A. Förster, Terence H. Rabbitts, Helen K. Angell, Anne Berger, Anna C. Obenauf and Michael R. Speicher and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Viia Valge-Archer

26 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Viia Valge-Archer United Kingdom 19 1.2k 1.1k 1.0k 373 238 27 2.4k
Stan Lipkowitz United States 23 978 0.8× 1.9k 1.7× 1.2k 1.2× 432 1.2× 235 1.0× 29 3.0k
Marialuisa Sensi Italy 27 1.8k 1.5× 1.4k 1.3× 1.1k 1.1× 287 0.8× 186 0.8× 92 2.9k
Yasuto Akiyama Japan 27 708 0.6× 878 0.8× 937 0.9× 332 0.9× 135 0.6× 128 2.2k
Els M.E. Verdegaal Netherlands 24 1.6k 1.3× 1.1k 1.0× 1.6k 1.6× 373 1.0× 156 0.7× 62 3.1k
Sandra Coral Italy 25 1.1k 0.9× 1.6k 1.4× 691 0.7× 270 0.7× 139 0.6× 53 2.3k
Timothy N. J. Bullock United States 31 2.1k 1.8× 798 0.7× 1.4k 1.4× 299 0.8× 181 0.8× 84 3.1k
Malin Pedersen United Kingdom 22 673 0.6× 1.3k 1.1× 1.1k 1.0× 293 0.8× 126 0.5× 37 2.4k
Rubén A. Bartolomé Spain 29 648 0.5× 1.1k 1.0× 1.0k 1.0× 493 1.3× 86 0.4× 48 2.3k
Orit Sagi‐Assif Israel 28 732 0.6× 961 0.9× 1.1k 1.0× 445 1.2× 131 0.6× 61 2.1k
Jean‐François Baurain Belgium 25 1.4k 1.2× 1.1k 1.0× 1.6k 1.6× 328 0.9× 316 1.3× 103 3.4k

Countries citing papers authored by Viia Valge-Archer

Since Specialization
Citations

This map shows the geographic impact of Viia Valge-Archer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viia Valge-Archer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viia Valge-Archer more than expected).

Fields of papers citing papers by Viia Valge-Archer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viia Valge-Archer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viia Valge-Archer. The network helps show where Viia Valge-Archer may publish in the future.

Co-authorship network of co-authors of Viia Valge-Archer

This figure shows the co-authorship network connecting the top 25 collaborators of Viia Valge-Archer. A scholar is included among the top collaborators of Viia Valge-Archer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viia Valge-Archer. Viia Valge-Archer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Dovedi, Simon J., Viia Valge-Archer, Amit Grover, et al.. (2023). Small Gene Networks Delineate Immune Cell States and Characterize Immunotherapy Response in Melanoma. Cancer Immunology Research. 11(8). 1125–1136. 2 indexed citations
3.
Walker, Jennifer A., Michelle Morrow, Viia Valge-Archer, et al.. (2023). Age-induced changes in anti-tumor immunity alter the tumor immune infiltrate and impact response to immuno-oncology treatments. Frontiers in Immunology. 14. 1258291–1258291. 9 indexed citations
4.
O’Donovan, Daniel H., David Baker, Giovanni Ciotta, et al.. (2023). Discovery and characterisation of quinazolines and 8-Azaquinazolines as NLRP3 agonists with oral bioavailability in mice. Bioorganic & Medicinal Chemistry Letters. 96. 129518–129518. 1 indexed citations
5.
Staniszewska, Anna D., Joshua Armenia, Matthew King, et al.. (2022). PARP inhibition is a modulator of anti-tumor immune response in BRCA-deficient tumors. OncoImmunology. 11(1). 2083755–2083755. 37 indexed citations
6.
Nakamura, Kyoko, Ankur Karmokar, Paul Farrington, et al.. (2021). Inhibition of DNA-PK with AZD7648 Sensitizes Tumor Cells to Radiotherapy and Induces Type I IFN-Dependent Durable Tumor Control. Clinical Cancer Research. 27(15). 4353–4366. 43 indexed citations
7.
Cribbs, Adam P., P. Filippakopoulos, Martin Philpott, et al.. (2021). Dissecting the Role of BET Bromodomain Proteins BRD2 and BRD4 in Human NK Cell Function. Frontiers in Immunology. 12. 626255–626255. 19 indexed citations
8.
Palazón, Asís, Edmund Poon, Maike de la Roche, et al.. (2019). A cell-engineered system to assess tumor cell sensitivity to CD8 + T cell-mediated cytotoxicity. OncoImmunology. 8(8). 1–10. 21 indexed citations
9.
Ghadially, Hormas, Lee R. Brown, Chris J. Lloyd, et al.. (2017). MHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissue. British Journal of Cancer. 116(9). 1208–1217. 83 indexed citations
10.
Zhu, Wei, Claire Germain, Yinong Sebastian, et al.. (2015). A high density of tertiary lymphoid structure B cells in lung tumors is associated with increased CD4+T cell receptor repertoire clonality. OncoImmunology. 4(12). e1051922–e1051922. 86 indexed citations
11.
Mlecnik, Bernhard, Gabriela Bindea, Helen K. Angell, et al.. (2014). Functional Network Pipeline Reveals Genetic Determinants Associated with in Situ Lymphocyte Proliferation and Survival of Cancer Patients. Science Translational Medicine. 6(228). 228ra37–228ra37. 165 indexed citations
12.
Angell, Helen K., Marie Tosolini, Bernhard Mlecnik, et al.. (2013). The impact of cellular senescence and DNA damage on colorectal tumour progression. Journal for ImmunoTherapy of Cancer. 1(S1). 1 indexed citations
13.
Vugmeyster, Yulia, Heath Guay, Pamela Szklut, et al.. (2010). In vitro potency, pharmacokinetic profiles and pharmacological activity of optimized anti-IL-21R antibodies in a mouse model of lupus. mAbs. 2(3). 335–346. 33 indexed citations
14.
Reichert, Janice M. & Viia Valge-Archer. (2007). Development trends for monoclonal antibody cancer therapeutics. Nature Reviews Drug Discovery. 6(5). 349–356. 289 indexed citations
15.
Valge-Archer, Viia, A. Förster, & Terence H. Rabbitts. (1998). The LMO1 and LDB1 proteins interact in human T cell acute leukaemia with the chromosomal translocation t(11;14)(p15;q11). Oncogene. 17(24). 3199–3202. 31 indexed citations
16.
Valge-Archer, Viia, et al.. (1994). The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells.. Proceedings of the National Academy of Sciences. 91(18). 8617–8621. 178 indexed citations
17.
McCaffrey, Patricia G., Peter K. Kim, Viia Valge-Archer, Ranjan Sen, & Anjana Rao. (1994). Cyclosporin A sensitivity of the NF-χB site of the IL2Rα promoter in untransformed murine T cells. Nucleic Acids Research. 22(11). 2134–2142. 40 indexed citations
18.
Jain, Jugnu, Viia Valge-Archer, & Anjana Rao. (1992). Analysis of the AP-1 sites in the IL-2 promoter. The Journal of Immunology. 148(4). 1240–1250. 166 indexed citations
19.
Jain, Jugnu, Viia Valge-Archer, Anthony J. Sinskey, & Anjana Rao. (1992). The AP-1 site at -150 bp, but not the NF-kappa B site, is likely to represent the major target of protein kinase C in the interleukin 2 promoter.. The Journal of Experimental Medicine. 175(3). 853–862. 66 indexed citations
20.
Valge-Archer, Viia, et al.. (1990). Transformation of T lymphocytes by the v- fos oncogene.. The Journal of Immunology. 145(12). 4355–4364. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stan Lipkowitz Breakdown of academic impact, for papers by Marialuisa Sensi Breakdown of academic impact, for papers by Yasuto Akiyama Breakdown of academic impact, for papers by Els M.E. Verdegaal Breakdown of academic impact, for papers by Sandra Coral Breakdown of academic impact, for papers by Timothy N. J. Bullock Breakdown of academic impact, for papers by Malin Pedersen Breakdown of academic impact, for papers by Rubén A. Bartolomé Breakdown of academic impact, for papers by Orit Sagi‐Assif Breakdown of academic impact, for papers by Jean‐François Baurain
Rankless by CCL
2026